PATENT CLAIM ANALYSIS

Application Number: 15769132
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "001100"]

Abstract:
Modified peptides based on C-terminal PDZ binding domains of PTEN and PHLPP, or PDK1 interacting fragment of PKN2 are described as are methods of using the modified peptides for blocking the activity of PTEN, PHLPP and PKN2 and treating sudden cardiac arrest. A method for guiding treatment of cardiac arrest based on sorbitol or taurine levels is also provided.

Claim (Index 7):
The pharmaceutical composition of  claim 6 , further comprising nicotinamide.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 91.0
- Lexical Diversity: 1.46512
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12466208', '14971432', '13002638', '13066700', '13885956']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7328674981275126
- 35 USC 102 Novelty (BERT): 0.5191011521940723
- Combined Prediction Score: 0.7114908635341686
- Mean Citation Score: 217.211942
- Max Citation Score: 227.78963
- Similarity Product: 113.7259267167729

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test